These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7910824)

  • 1. A unique interhelical insertion in plasminogen activator inhibitor-2 contains three glutamines, Gln83, Gln84, Gln86, essential for transglutaminase-mediated cross-linking.
    Jensen PH; Schüler E; Woodrow G; Richardson M; Goss N; Højrup P; Petersen TE; Rasmussen LK
    J Biol Chem; 1994 May; 269(21):15394-8. PubMed ID: 7910824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type-2 plasminogen-activator inhibitor is a substrate for trophoblast transglutaminase and factor XIIIa. Transglutaminase-catalyzed cross-linking to cellular and extracellular structures.
    Jensen PH; Lorand L; Ebbesen P; Gliemann J
    Eur J Biochem; 1993 May; 214(1):141-6. PubMed ID: 8099547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-linking of plasminogen activator inhibitor 2 and alpha 2-antiplasmin to fibrin(ogen).
    Ritchie H; Lawrie LC; Crombie PW; Mosesson MW; Booth NA
    J Biol Chem; 2000 Aug; 275(32):24915-20. PubMed ID: 10816585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The C-D interhelical domain of the serpin plasminogen activator inhibitor-type 2 is required for protection from TNF-alpha induced apoptosis.
    Dickinson JL; Norris BJ; Jensen PH; Antalis TM
    Cell Death Differ; 1998 Feb; 5(2):163-71. PubMed ID: 10200461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of transglutaminase-reactive residues in S100A11.
    Robinson NA; Eckert RL
    J Biol Chem; 1998 Jan; 273(5):2721-8. PubMed ID: 9446578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Gln726 in nidogen as the amine acceptor in transglutaminase-catalyzed cross-linking of laminin-nidogen complexes.
    Aeschlimann D; Paulsson M; Mann K
    J Biol Chem; 1992 Jun; 267(16):11316-21. PubMed ID: 1350783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly sulfated glycosaminoglycans augment the cross-linking of vitronectin by guinea pig liver transglutaminase. Functional studies of the cross-linked vitronectin multimers.
    Sane DC; Moser TL; Parker CJ; Seiffert D; Loskutoff DJ; Greenberg CS
    J Biol Chem; 1990 Feb; 265(6):3543-8. PubMed ID: 1689304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Location of the major epsilon-(gamma-glutamyl)lysyl cross-linking site in transglutaminase-modified human plasminogen.
    Bendixen E; Harpel PC; Sottrup-Jensen L
    J Biol Chem; 1995 Jul; 270(30):17929-33. PubMed ID: 7629099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gly-Pro-Arg-Pro modifies the glutamine residues in the alpha- and gamma-chains of fibrinogen: inhibition of transglutaminase cross-linking.
    Achyuthan KE; Dobson JV; Greenberg CS
    Biochim Biophys Acta; 1986 Aug; 872(3):261-8. PubMed ID: 2873839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of crosslinking sites in fibrinogen for plasminogen activator inhibitor 2 (PAI-2).
    Ritchie H; Lawrie LC; Mosesson MW; Booth NA
    Ann N Y Acad Sci; 2001; 936():215-8. PubMed ID: 11460477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two adjacent N-terminal glutamines of BM-40 (osteonectin, SPARC) act as amine acceptor sites in transglutaminaseC-catalyzed modification.
    Hohenadl C; Mann K; Mayer U; Timpl R; Paulsson M; Aeschlimann D
    J Biol Chem; 1995 Oct; 270(40):23415-20. PubMed ID: 7559501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The exon 3 encoded sequence of the intracellular serine proteinase inhibitor plasminogen activator inhibitor 2 is a protein binding domain.
    Jensen PH; Jensen TG; Laug WE; Hager H; Gliemann J; Pepinsky B
    J Biol Chem; 1996 Oct; 271(43):26892-9. PubMed ID: 8900173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monocyte plasminogen activator inhibitor 2 (PAI-2) inhibits u-PA-mediated fibrin clot lysis and is cross-linked to fibrin.
    Ritchie H; Robbie LA; Kinghorn S; Exley R; Booth NA
    Thromb Haemost; 1999 Jan; 81(1):96-103. PubMed ID: 10348718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasminogen activator inhibitor-2 is expressed in different types of congenital ichthyosis: in vivo evidence for its cross-linking into the cornified cell envelope by transglutaminase-1.
    Oji V; Oji ME; Adamini N; Walker T; Aufenvenne K; Raghunath M; Traupe H
    Br J Dermatol; 2006 May; 154(5):860-7. PubMed ID: 16634887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro modification of betaine-homocysteine S-methyltransferase by tissue-type transglutaminase.
    Ichikawa A; Ohashi Y; Terada S; Natsuka S; Ikura K
    Int J Biochem Cell Biol; 2004 Oct; 36(10):1981-92. PubMed ID: 15203112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transglutaminases catalyze cross-linking of plasminogen to fibronectin and human endothelial cells.
    Bendixen E; Borth W; Harpel PC
    J Biol Chem; 1993 Oct; 268(29):21962-7. PubMed ID: 8104945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence location of a putative transglutaminase cross-linking site in human vitronectin.
    Skorstengaard K; Halkier T; Højrup P; Mosher D
    FEBS Lett; 1990 Mar; 262(2):269-74. PubMed ID: 1692291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen-activator inhibitor type 2 (PAI-2) is a spontaneously polymerising SERPIN. Biochemical characterisation of the recombinant intracellular and extracellular forms.
    Mikus P; Urano T; Liljeström P; Ny T
    Eur J Biochem; 1993 Dec; 218(3):1071-82. PubMed ID: 7506655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The glutamine residues reactive in transglutaminase-catalyzed cross-linking of involucrin.
    Simon M; Green H
    J Biol Chem; 1988 Dec; 263(34):18093-8. PubMed ID: 2461365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-linking of galectin 3, a galactose-binding protein of mammalian cells, by tissue-type transglutaminase.
    Mehul B; Bawumia S; Hughes RC
    FEBS Lett; 1995 Feb; 360(2):160-4. PubMed ID: 7875321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.